{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:41:43Z","timestamp":1761514903565},"reference-count":31,"publisher":"Walter de Gruyter GmbH","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jpem-2022-0222_abs_001\">\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Lockdown during the SARS-CoV-2 pandemic generated uncertainty regarding its effects on the control of type 1 diabetes (DM1). Our study aims to evaluate the influence of the pandemic on the control of paediatric patients with DM1.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2022-0222_abs_002\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Longitudinal, retrospective, observational study in patients with DM1 attended between 15\/10\/2019 and 15\/03\/2020. Data were collected at that visit and at the three subsequent visits. The second was remote in 50% of cases. The variables analysed were: type of insulin therapy, time in range (TIR), time in hypoglycaemia (THypo), time in hyperglycaemia (THyper), coefficient of variation (CV), glycosylated haemoglobin, insulin requirements and anthropometric data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2022-0222_abs_003\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>157 patients were recruited. At the post-lockdown visit, the TIR increased and the THyper decreased with respect to the first (p&lt;0.00) and second (p&lt;0.00) visits. Patients treated with subcutaneous infusion showed a higher TIR at the third visit (p=0.03) and lower insulin requirements at the fourth visit (p=0.03) compared to patients treated with multiple doses. Patients with a remote visit presented a higher TIR (p&lt;0.00), a lower THyper (p=0.00) and lower insulin requirements (p=0.01) at the next visit. Patients aged less than 6\u00a0years presented a lower glycosylated haemoglobin (p=0.01) and insulin requirements at the third (p=0.03) and fourth (p=0.01) visits, and a lower increase in body mass index (p=0.03) over the year.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2022-0222_abs_004\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Metabolic control improved at the post-lockdown visit. Patients treated with subcutaneous infusion, those who had a remote visit during strict lockdown and those aged less than 6\u00a0years had a better evolution.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpem-2022-0222","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T03:50:00Z","timestamp":1653623400000},"page":"867-873","source":"Crossref","is-referenced-by-count":4,"title":["Influence of the SARS-CoV-2 pandemic on paediatric patients with type 1 diabetes mellitus after one year of follow-up"],"prefix":"10.1515","volume":"35","author":[{"given":"Ver\u00f3nica","family":"Gimeno-Hern\u00e1ndez Garza","sequence":"first","affiliation":[{"name":"Pediatrics , Hospital Universitario Miguel Servet , Zaragoza , Arag\u00f3n , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Anto\u00f1anzas Torres","sequence":"additional","affiliation":[{"name":"Pediatrics , Hospital Universitario Miguel Servet , Zaragoza , Arag\u00f3n , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Pitarch Roca","sequence":"additional","affiliation":[{"name":"Pediatrics , Hospital Universitario Miguel Servet , Zaragoza , Arag\u00f3n , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"V\u00e1zquez S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Pediatrics , Hospital Universitario Miguel Servet , Zaragoza , Arag\u00f3n , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Ferrer Lozano","sequence":"additional","affiliation":[{"name":"Pediatrics , Hospital Universitario Miguel Servet , Zaragoza , Arag\u00f3n , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"de Arriba Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Pediatrics , Hospital Universitario Miguel Servet , Zaragoza , Arag\u00f3n , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2022,5,30]]},"reference":[{"key":"2023033122065293483_j_jpem-2022-0222_ref_001","unstructured":"Barrero, J, Cabanas, P, Castro, L, Pombo, M. Tratado de endocrinolog\u00eda pedi\u00e1trica. In: McGraw-Hill Interamericana, 4th ed Madrid: Pombo M; 2009:748\u20139 pp."},{"key":"2023033122065293483_j_jpem-2022-0222_ref_002","unstructured":"Guerrero-Fernandez, J, G\u00f3nzalez, I. Manual de diagn\u00f3stico y terap\u00e9utica en Endocrinolog\u00eda Pedi\u00e1trica v.1.0. Madrid: MajadahondaErg\u00f3n; 2018:119\u201329 pp."},{"key":"2023033122065293483_j_jpem-2022-0222_ref_003","doi-asserted-by":"crossref","unstructured":"Maahs, DM, West, NA, Lawrence, JM, Mayer-Davis, EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin N Am 2010;39:481\u201397. https:\/\/doi.org\/10.1016\/j.ecl.2010.05.011.","DOI":"10.1016\/j.ecl.2010.05.011"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_004","unstructured":"Contreras, JR, Gonz\u00e1lez Casado, I. Manejo y seguimiento del ni\u00f1o diab\u00e9tico. Pediatr Integr 2015;XIX:456\u201366."},{"key":"2023033122065293483_j_jpem-2022-0222_ref_005","doi-asserted-by":"crossref","unstructured":"Ghosh, R, Dubey, MJ, Chatterjee, S, Dubey, S. Impact of COVID-19 on children: Special focus on the psychosocial aspect. Minerva Pediatrica. Edizioni Minerva Medica 2020;72:226\u201335. https:\/\/doi.org\/10.23736\/s0026-4946.20.05887-9.","DOI":"10.23736\/S0026-4946.20.05887-9"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_006","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez Conejero, M, Gonz\u00e1lez de Buitrago Amigo, J, Tejado Bravo, ML, de Nicol\u00e1s Jim\u00e9nez, JM. Impact of COVID-19 lockdown on glucemic control in children and adolescents with type 1 diabetes mellitus An Pediatr [Internet]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33637472 [Accessed 23 Jan 2021].","DOI":"10.1016\/j.anpede.2020.12.022"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_007","doi-asserted-by":"crossref","unstructured":"Ohannessian, R, Duong, TA, Odone, A. Global telemedicine implementation and integration within health systems to fight the COVID-19 pandemic: a call to action. JMIR Public Heal Surveill 2020;6:e18810. https:\/\/doi.org\/10.2196\/18810.","DOI":"10.2196\/18810"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_008","doi-asserted-by":"crossref","unstructured":"Almonacid, C, Blanco-Aparicio, M, Dom\u00ednguez-Ortega, J, Giner, J, Molina, J, Plaza, V. Teleconsultation in the follow-up of the asthma patient. lessons after COVID-19. Archivos de Bronconeumologia. (Elsevier Doyma) 2021;57:13\u20134. https:\/\/doi.org\/10.1016\/j.arbres.2020.10.005.","DOI":"10.1016\/j.arbres.2020.10.005"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_009","doi-asserted-by":"crossref","unstructured":"Hernando-Requejo, V, Huertas-Gonz\u00e1lez, N, Lape\u00f1a-Motilva, J, Ogando-Dur\u00e1n, G. The epilepsy unit during the COVID-19 epidemic: the role of telemedicine and the effects of confinement on patients with epilepsy. Neurologia 2020;35:274\u20136. https:\/\/doi.org\/10.1016\/j.nrleng.2020.04.012.","DOI":"10.1016\/j.nrleng.2020.04.012"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_010","doi-asserted-by":"crossref","unstructured":"Ozsezen, B, Emiralioglu, N, Tural, DA, Sunman, B, Buyuksahin, HN, Yalcin, E, et al.. Telephone surveillance during 2019 novel coronavirus disease: is it a helpful diagnostic tool for detecting acute pulmonary exacerbations in children with chronic lung disease? J Telemed Telecare 2020. https:\/\/doi.org\/10.1177\/1357633X20972008.","DOI":"10.1177\/1357633X20972008"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_032","doi-asserted-by":"crossref","unstructured":"Carrascosa, A, Fern\u00e1ndez, J, Fern\u00e1ndez, C, Ferr\u00e1ndez, A, L\u00f3pez-Siguero, JP, S\u00e1ncez, E, et al.. Estudio transversal espa\u00f1ol de crecimiento 2008. Parte II: valores de talla, peso e \u00edndice de masa corporal desde el nacimiento a la talla adulta. An Pediatr (Barc). 2008;68:552\u201369.","DOI":"10.1157\/13123287"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_012","doi-asserted-by":"crossref","unstructured":"Ghosal, S, Sinha, B, Majumder, M, Misra, A. Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: a simulation model using multivariate regression analysis. Diabetes Metab Syndr Clin Res Rev 2020;14:319\u201323. https:\/\/doi.org\/10.1016\/j.dsx.2020.03.014.","DOI":"10.1016\/j.dsx.2020.03.014"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_013","doi-asserted-by":"crossref","unstructured":"Tornese, G, Ceconi, V, Monasta, L, Carletti, C, Faleschini, E, Barbi, E. Glycemic control in type 1 diabetes mellitus during COVID-19 quarantine and the role of in-home physical activity. Diabetes Technol Ther 2020;22:462\u20137. https:\/\/doi.org\/10.1089\/dia.2020.0169.","DOI":"10.1089\/dia.2020.0169"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_014","doi-asserted-by":"crossref","unstructured":"Aragona, M, Rodia, C, Bertolotto, A, Campi, F, Coppelli, A, Giannarelli, R, et al.. Type 1 diabetes and COVID-19: the \u201clockdown effect\u201d. Diabetes Res Clin Pract 2020;170:108468. https:\/\/doi.org\/10.1016\/j.diabres.2020.108468.","DOI":"10.1016\/j.diabres.2020.108468"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_015","doi-asserted-by":"crossref","unstructured":"Caruso, I, Di Molfetta, S, Guarini, F, Giordano, F, Cignarelli, A, Natalicchio, A, et al.. Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS-CoV-2 outbreak in type 1 diabetes. Diabetes Metab Res Rev 2021;37:e3404. https:\/\/doi.org\/10.1002\/dmrr.3404.","DOI":"10.1002\/dmrr.3404"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_016","doi-asserted-by":"crossref","unstructured":"Hakonen, E, Varimo, T, Tuomaala, A-K, Miettinen, PJ, Pulkkinen, M-A. The effect of COVID-19 lockdown on the glycemic control of children with type 1 diabetes. BMC Pediatr 2022;22:48. https:\/\/doi.org\/10.1186\/s12887-022-03115-6.","DOI":"10.1186\/s12887-022-03115-6"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_017","doi-asserted-by":"crossref","unstructured":"Brener, A, Mazor-Aronovitch, K, Rachmiel, M, Levek, N, Barash, G, Pinhas-Hamiel, O, et al.. Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown. Acta Diabetol 2020;57:1511\u20137. https:\/\/doi.org\/10.1007\/s00592-020-01596-4.","DOI":"10.1007\/s00592-020-01596-4"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_018","doi-asserted-by":"crossref","unstructured":"Christoforidis, A, Kavoura, E, Nemtsa, A, Pappa, K, Dimitriadou, M. Coronavirus lockdown effect on type 1 diabetes management \u03bfn children wearing insulin pump equipped with continuous glucose monitoring system. Diabetes Res Clin Pract 2020;166:108307. https:\/\/doi.org\/10.1016\/j.diabres.2020.108307.","DOI":"10.1016\/j.diabres.2020.108307"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_019","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez, E, Cortazar, A, Bellido, V. Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes. Diabetes Res Clin Pract 2020;166:108348. https:\/\/doi.org\/10.1016\/j.diabres.2020.108348.","DOI":"10.1016\/j.diabres.2020.108348"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_020","doi-asserted-by":"crossref","unstructured":"Vi\u00f1als, C, Mesa, A, Roca, D, Vidal, M, Pueyo, I, Conget, I, et al.. Management of glucose profile throughout strict COVID-19 lockdown by patients with type 1 diabetes prone to hypoglycaemia using sensor-augmented pump. Acta Diabetol 2021;58:383\u20138. https:\/\/doi.org\/10.1007\/s00592-020-01625-2.","DOI":"10.1007\/s00592-020-01625-2"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_021","doi-asserted-by":"crossref","unstructured":"Mesa, A, Vi\u00f1als, C, Pueyo, II, Roca, D, Vidal, M, Gim\u00e9nez, M, et al.. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring. Diabetes Res Clin Pract 2020;167:108354. https:\/\/doi.org\/10.1016\/j.diabres.2020.108354.","DOI":"10.1016\/j.diabres.2020.108354"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_022","doi-asserted-by":"crossref","unstructured":"Bonora, BM, Boscari, F, Avogaro, A, Bruttomesso, D, Fadini, GP. Glycaemic control among people with type 1 diabetes during lockdown for the SARS-CoV-2 outbreak in Italy. Diabetes Ther 2020;11:1369\u201379. https:\/\/doi.org\/10.1007\/s13300-020-00829-7.","DOI":"10.1007\/s13300-020-00829-7"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_023","doi-asserted-by":"crossref","unstructured":"Capaldo, B, Annuzzi, G, Creanza, A, Giglio, C, De Angelis, R, Lupoli, R, et al.. Blood glucose control during lockdown for COVID-19: cgm metrics in Italian adults with type 1 diabetes. Diabetes Care 2020;43:88\u20139. https:\/\/doi.org\/10.2337\/dc20-1127.","DOI":"10.2337\/dc20-1127"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_024","doi-asserted-by":"crossref","unstructured":"Dover, AR, Ritchie, SA, McKnight, JA, Strachan, MWJ, Zammitt, NN, Wake, DJ, et al.. Assessment of the effect of the COVID-19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring. Diabet Med 2021;38:1\u20138. https:\/\/doi.org\/10.1111\/dme.14374.","DOI":"10.1111\/dme.14374"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_025","doi-asserted-by":"crossref","unstructured":"Ruissen, MM, Regeer, H, Landstra, CP, Schroijen, M, Jazet, I, Nijhoff, MF, et al.. Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic. BMJ Open Diabetes Res Care 2021;9:2035. https:\/\/doi.org\/10.1136\/bmjdrc-2020-002035.","DOI":"10.1136\/bmjdrc-2020-002035"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_026","doi-asserted-by":"crossref","unstructured":"Hartmann, B, Tittel, SR, Femerling, M, Pfeifer, M, Meyh\u00f6fer, S, Lange, K, et al.. COVID-19 lockdown periods in 2020: good maintenance of metabolic control in adults with type 1 and type 2 diabetes. Exp Clin Endocrinol Diabetes 2022. https:\/\/doi.org\/10.1055\/a-1743-2537.","DOI":"10.1055\/a-1743-2537"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_027","doi-asserted-by":"crossref","unstructured":"Verma, A, Rajput, R, Verma, S, Balania, VKB, Jangra, B. Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus. Diabetes Metab Syndr Clin Res Rev 2020;14:1213\u20136. https:\/\/doi.org\/10.1016\/j.dsx.2020.07.016.","DOI":"10.1016\/j.dsx.2020.07.016"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_028","doi-asserted-by":"crossref","unstructured":"Odeh, R, Gharaibeh, L, Daher, A, Kussad, S, Alassaf, A. Caring for a child with type 1 diabetes during COVID-19 lockdown in a developing country: challenges and parents\u2019 perspectives on the use of telemedicine. Diabetes Res Clin Pract 2020;168:108393. https:\/\/doi.org\/10.1016\/j.diabres.2020.108393.","DOI":"10.1016\/j.diabres.2020.108393"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_029","doi-asserted-by":"crossref","unstructured":"Ojo, O, Wang, X-H, Ojo, OO, Orjih, E, Pavithran, N, Rodrigues, A, et al.. The effects of COVID-19 lockdown on glycaemic control and lipid profile in patients with type 2 diabetes: a systematic review and meta-analysis. Int J Environ Res Publ Health 2022;19:1095. https:\/\/doi.org\/10.3390\/ijerph19031095.","DOI":"10.3390\/ijerph19031095"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_030","doi-asserted-by":"crossref","unstructured":"Duarte, V, Mota, B, Ferreira, S, Costa, C, Correia, CC. Impact of COVID-19 lockdown on glycemic control in type 1 diabetes. Arch Pediatr 2022;29:27\u20139. https:\/\/doi.org\/10.1016\/j.arcped.2021.11.008.","DOI":"10.1016\/j.arcped.2021.11.008"},{"key":"2023033122065293483_j_jpem-2022-0222_ref_031","doi-asserted-by":"crossref","unstructured":"Schiaffini, R, Barbetti, F, Rapini, N, Inzaghi, E, Deodati, A, Patera, IP, et al.. School and pre-school children with type 1 diabetes during Covid-19 quarantine: the synergic effect of parental care and technology. Diabetes Res Clin Pract 2020;166:108302. https:\/\/doi.org\/10.1016\/j.diabres.2020.108302.","DOI":"10.1016\/j.diabres.2020.108302"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2022-0222\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2022-0222\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T11:27:25Z","timestamp":1680348445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2022-0222\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,5,30]]},"published-print":{"date-parts":[[2022,7,26]]}},"alternative-id":["10.1515\/jpem-2022-0222"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2022-0222","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,30]]}}}